Cleared Abbreviated

K091054 - WALK400H

K091054 is an FDA 510(k) clearance for WALK400H, manufactured by Et Medical Devices Spa. The device is a Class 2 Cardiovascular device with product code MWJ cleared through the Abbreviated 510(k) pathway after a 105-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2009
Decision
105d
Days
Class 2
Risk

K091054 is an FDA 510(k) clearance for the WALK400H. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by Et Medical Devices Spa (Cavareno(Tn), IT). The FDA issued a Cleared decision on July 27, 2009 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Et Medical Devices Spa devices

FDA 510(k) Submission Details - K091054

510(k) Number K091054 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2009
Decision Date July 27, 2009
Days to Decision 105 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 125d · This submission: 105d
Pathway characteristics
Standards-based clearance path.

MWJ Device Classification - Class 2, Special Controls

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 21
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K091054.
Integrated CardioRespiratory System
K173156 · Sensydia, Inc. · Jun 2018
H3+ Holter Recorder
K152626 · Mortara Instrument, Inc. · Feb 2016
BTL-08 ECG RECORDER MODEL BTL-08 ECG LC PLUS, BTL-08 ECG LT PLUS
K100310 · BTL Industries, Inc. · Oct 2010
SEER LIGHT EXTEND COMPACT DIGITAL HOLTER SYSTEM
K050731 · Ge Medical Systems Information Technologies · May 2005
HOLTER RECORDER H3+
K043010 · Mortara Instrument, Inc. · Feb 2005
SPIDERVIEW
K032466 · Ela Medical, Inc. · Aug 2003